Actively Recruiting
Ceramic Modular Dual Mobility in Primary Total Hip Arthroplasty (THA)
Led by Aesculap AG · Updated on 2025-12-16
100
Participants Needed
1
Research Sites
297 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A randomized controlled trial comparing modular dual mobility inserts with ceramic multilayer coating versus standard polyethylene inserts for primary THA in a cementless acetabular cup
CONDITIONS
Official Title
Ceramic Modular Dual Mobility in Primary Total Hip Arthroplasty (THA)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with primary coxarthrosis indicated for cementless total hip arthroplasty
- Written informed consent given by the patient
- Age 18 years or older
You will not qualify if you...
- History of hip trauma or revision surgery
- Presence of rheumatoid or neurological disease
- Body mass index (BMI) over 35
- Ongoing cancer treatment
- Preoperative cobalt or chromium serum levels above 1.0 g/L
- Other joint implants or planned joint replacement surgery during the study period
- Expected acetabular cup size smaller than 52
- Inability to comply mentally or physically with study requirements and follow-up visits
- Patients younger than 18 years at surgery
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Masaryk Hospital
Ústí nad Labem, Czechia
Actively Recruiting
Research Team
L
Lutz Dreyer, Dr.
CONTACT
S
Stefan Maenz, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here